Achieving Seamless Transition and Manufacturing Readiness
NueCell Bio helps clients achieve manufacturing readiness through process and analytical method transfer packages, draft batch records, risk assessments, and technology transfer documentation to enable successful GMP implementation at your CDMO of choice and future regulatory submissions.
Tech Transfer & Gap Assessment
Our team has spent years developing technology transfer processes that support a clean handoff for GMP manufacturing.
- Locked, transferable process package
- Risk & gap-mitigation plans
- Replicate-grade execution at GMP partner
- Project intake meets the science where it is
- Accelerates qualification at the receiving GMP CDMO
Locking the Process for Transfer
We lock the developed process and analytics and execute mid- to full-scale confirmation runs prior to tech transfer, generating the data package needed for GMP readiness. Confirmation runs are designed within the operating ranges established during characterization, with the full analytical control strategy — release assays, in-process controls, and stability-indicating methods — deployed as they will run at the manufacturing site.
We work closely with your CDMO of choice on operator training, batch record implementation, and side-by-side execution, leveraging our internal transfer playbook to ensure the process performs as it did at NueCell Bio.
OUR EXPERTISE
Wide-Ranging Modality Expertise
Cell Types
- Primary cells (T, NK, Myeloid, etc.)
- Stem & progenitor cells (HSC, PSC, MSC, etc.)
- Specialized cells (differentiated stem cells, primary therapeutic cells)
Product architecture
- Autologous
- Adherent
- Scale-up
- Allogeneic
- Suspension
- Scale-out
Engineering Capabilities
- Gene editing
- Viral delivery
- Non-viral delivery
- Cellular reprogramming
